Literature DB >> 18715201

Influence of diabetes on the validity glaucoma screening by frequency doubling perimetry: a hospital-based study in Oman.

Rajiv Khandekar1, Rajiv Zutshi, Mohammed Ali, Abdulatif Al Raisi, Henry Dass.   

Abstract

BACKGROUND: A hospital-based study was conducted in 2007 in Oman to determine the validity of frequency doubling perimetry (FDP). The authors have compared the ability of FDP to detect glaucoma among patients with and without diabetes.
METHODS: This was a validity study of the screening procedure. An ophthalmologist and an optometrist examined Omani persons >30 years of age with and without diabetes. They determined glaucomatous field changes by using FDP. The glaucoma specialist labeled the eye and the person as suffering from glaucoma if two criteria were present: (1) optic cup disc and other retinal changes suggestive of glaucoma and (2) field changes on automated perimeter suggestive of glaucoma. Ocular pressure was measured with a Tono-Pen (Medtronic Ophthalmics, Jacksonville, FL). We calculated the validity of glaucoma screening by FDP among persons both with diabetes and without diabetes.
RESULTS: We examined 111 eyes of 56 Omani patients (55 eyes of 28 patients with diabetes and 56 eyes of 28 persons without diabetes). Two persons had a history of glaucoma in both eyes. Glaucoma screening by FDP detected five eyes (two eyes of patients with diabetes and three eyes of persons without diabetes) with glaucoma. The specificity of glaucoma screening among those with and without diabetes was 97.4% and 97.3%, respectively. The sensitivity was 6% and 11%, respectively, in these two groups.
CONCLUSIONS: Validity of glaucoma screening by FDP is not different among those with and without diabetes. In countries with high rates of diabetes, FDP could be used as a first-level screening tool for glaucoma.

Entities:  

Mesh:

Year:  2008        PMID: 18715201     DOI: 10.1089/dia.2007.0272

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  2 in total

1.  THE ROLE OF FREQUENCY DOUBLING TECHNOLOGY PERIMETRY IN EARLY DETECTION OF DIABETIC RETINOPATHY.

Authors:  Mario Bradvica; Dubravka Biuk; Ivanka Štenc Bradvica; Maja Vinković; Branimir Cerovski; Ivona Barać
Journal:  Acta Clin Croat       Date:  2020-03       Impact factor: 0.932

2.  Validity, Usefulness and Cost of RETeval System for Diabetic Retinopathy Screening.

Authors:  Humoud Al-Otaibi; Mohammed D Al-Otaibi; Rajiv Khandekar; Ches Souru; Abdulelah A Al-Abdullah; Hassan Al-Dhibi; Donald U Stone; Igor Kozak
Journal:  Transl Vis Sci Technol       Date:  2017-05-16       Impact factor: 3.283

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.